Arnebia euchroma polysaccharides inhibit expression of inflammation-related cytokines in LPS-stimulated PBMC

LIU Chun-Hong,WANG Wei,WANG Jing,ZHU Hong-Wei,LIU Xiao-Ying,JIANG Yun,WANG Xun,CHEN Dao-Feng,CAO Wen-Jun,QU Di
DOI: https://doi.org/10.3969/j.issn.1000-484X.2011.04.008
2011-01-01
Abstract:Objective:To study the effects of Arnebia euchroma polysaccharides on TNF-α,IL-10 and IL-18.mRNA expression in LPS-stimulated peripheral blood mononuclear cells(PBMC) and to explore the possible signaling pathways.Methods:PBMC were isolated from peripheral blood of healthy people by LymphopreTM.After the treatment of culturing human peripheral blood mononuclear cells(PBMC) or LPS stimulated PBMC,in presence or absence of Arnebia euchroma polysaccharides the transcription levels of TNF-α,IL-10,IL-18,IL-18BP,IL-18Rα,IL-18Rβ were detected by Real-time RT-PCR.The phosphorylation of ERK in PBMC was detected by Western blot.Results:The transcription levels of TNF-α,IL-10,IL-18Rα and IL-18Rβ in PBMC induced by Arnebia euchroma polysaccharides were similar to that treated by LPS.Arnebia euchroma polysaccharides inhibited transcription of inflammatory mediators,TNF-α and IL-18 mRNA at 4 h in LPS-stimulated PBMC(inhibition ratio,15%-50%,P<0.05),and inhibited LPS-induced phosphorylation of ERK(inhibition ratio,27%-61%,P<0.05).Conclusion:Arnebia euchroma polysaccharides may inhibit LPS-induced TNF-α expression in LPS-stimulated PBMC via down-regulation of MAPK signaling pathway.
What problem does this paper attempt to address?